Personalised analytics for rare disease diagnostics
Genome sequencing is being widely adopted for diagnosis of genetic diseases, but identifying the causal variants remains challenging. Here, the authors introduce a tool that incorporates tissue-specific gene expression data into predicting variant pathogenicity, improving accuracy.
Guardado en:
Autores principales: | Denise Anderson, Gareth Baynam, Jenefer M. Blackwell, Timo Lassmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/63acb38dd4c14d16b5884b95ac16f5b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening
por: Lorna J. Hale, et al.
Publicado: (2018) -
Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
por: Kartik Kumar, et al.
Publicado: (2021) -
Community capital and the role of the state: an empowering approach to personalisation
por: Patricia Jones
Publicado: (2013) -
The effect of protein mutations on drug binding suggests ensuing personalised drug selection
por: Shunzhou Wan, et al.
Publicado: (2021) -
Possibilities for personalised medicine in rheumatoid arthritis: hype or hope
por: Pascal Hendrik Pieter de Jong, et al.
Publicado: (2021)